To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure email@example.com
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
The discussion of future fertility options should be considered an essential part of the treatment plan for young women having gonadotoxic therapy. Given the toxic effects of chemotherapy agents on the ovary, with the resultant risk of temporary and more permanent ovarian failure, the availability of options to preserve and protect fertility is of great importance to these young women and their families. Current options to preserve fertility in this patient population of women who undergo chemotherapy treatment are limited, but include preservation of embryos, oocytes, or ovarian tissue prior to cancer treatment, and ovarian protection with the use of gonadotropin-releasing hormone (GnRH) analogues throughout the duration of treatment. As the most extensively investigated endocrine marker, serum follicle-stimulating hormone (FSH) has been the most useful parameter for assessment of ovarian reserve. A combination of endocrine and biophysical parameters provides the best insight currently available into current and future ovarian function.